|
In light of the new Bioscreen laboratory tests for CFIDS (urinary markers CFIDSUM1, B15, etc.), it is noteworthy that four Australian patients who, after following Dr Petrovic's research-based treatment procedure, were found to no longer meet the CDC CFIDS criteria, also showed an absence of their previously detected urinary CFIDS markers.
These preliminary observations suggest a possible correlation between clinical improvement and changes in Bioscreen laboratory markers; however, further independent verification and controlled research would be required to confirm these findings.
Disclaimer:
This website is maintained for historical and reference purposes only.
The Petrovic CFIDS Health Center has permanently closed its physical premises.
All information is presented for educational and research reference, not for clinical use or medical diagnosis.
|